Infinity Pharmaceuticals: Completion of Phase I/II Trials May Drive Stock

Published November 28, 2012

Infinity Pharmaceuticals: Completion Of Phase I/II Trials May Drive Stock

Filed under: drug treatment news articles

With regard to Heat shock protein 90 inhibitors in NSCLC, there are at present two other drugs in the same class intended to treat NSCLC: Synta's ganetespib (SNTA) and Novartis' NVP-AUY-922 (NVS). Ganetespib initial interim results published in June …
Read more on Seeking Alpha

Statin Anti-Cholesterol Drugs Revisited

Filed under: drug treatment news articles

Due to a belief that cholesterol causes coronary artery disease, statin drug reduction of cholesterol is a mainstream medical treatment intended to prevent heart disease. Do statin drugs prevent … This article will answer that question. Anti …
Read more on OpEdNews

Nadya Suleman's rehab: Octomom's father enters rehab with daughter

Filed under: drug treatment news articles

Nadya Suleman's rehab stint inside Chapman House Rehabilitation Center is only a week old, but she's already been joined at the center by her own dad, Ed Doud. According to Zap2It.com, Doud has entered rehab in hopes of curing his addiction to alcohol.
Read more on Examiner.com